Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

PURPOSE: To assess short-term functional and anatomical outcomes of refractory diabetic macular edema (DME) following a switch from ranibizumab or dexamethasone to aflibercept. METHODS: We included retrospectively eyes with persistent DME after at least 3 ranibizumab and/or one dexamethasone implant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Ophthalmol
Asıl Yazarlar: Herbaut, Antoine, Fajnkuchen, Franck, Qu-Knafo, Lise, Nghiem-Buffet, Sylvia, Bodaghi, Bahram, Giocanti-Auregan, Audrey
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2017
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576400/
https://ncbi.nlm.nih.gov/pubmed/28900543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8035013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller